Hyalose LLC
- Company typePrivate
- Founded-
- HeadquartersSalt Lake City, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Hyalose LLC firmographics
Firmographics- Name
- Hyalose LLC
- Website
- https://hyalose.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Hyalose LLC is headquartered
LocationHeadquarters
- HQ city
- Salt Lake City
- HQ country
- United States
- HQ region
- North America
Markets served
Hyalose LLC business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
Hyalose LLC product offering
Product offeringCore offering
Hyalose LLC is a biotechnology company focused on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HA). The firm leverages proprietary recombinant bioprocesses to manufacture HA as a tangible biopolymer product intended for downstream business customers in pharmaceutical, cosmetic, dermatological, ophthalmic, and medical device applications.
Product overview
No product or service information available. The source data is from a domain name listing page on HugeDomains.com showing that the domain hyalose.com is for sale for $6,895. No information about Hyalose LLC's actual products, services, or business operations is provided in this source.
Differentiator
Problem solved
Functional benefit
Products and services
- Recombinant Hyaluronic Acid (HA) Hyaluronic Acid produced via the company's proprietary recombinant bioprocess technology, sold as a tangible biopolymer raw material or ingredient to business customers in pharmaceutical, cosmetic, and medical device manufacturing.
Companies that use Hyalose LLC
Customer profileIdeal customer profiles1 record
Hyalose LLC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Hyalose LLC partnerships and signals
Strategic signalRecent moves1 record
Hyalose LLC competitors and assessment
Company assessmentBroad incumbents
- Bloomage Biotech: The world's largest hyaluronic acid producer, supplying fermentation-grade HA across cosmetics, medical, and food grades. Directly comparable to Hyalose as a HA manufacturer but at vastly greater scale and with established global customers.
- AbbVie (Allergan Aesthetics): Markets Juvederm, the leading HA-based dermal filler franchise. Comparable as a major downstream buyer and formulator of HA, and a potential strategic acquirer of differentiated HA supply technologies.
- Galderma: Global dermatology leader with the Restylane HA-based filler portfolio. Comparable as a large-scale HA aesthetics consumer and a potential strategic partner for differentiated, high-purity HA supply.
- Merz Aesthetics: Global aesthetics company with the Belotero and Radiesse portfolios, including HA-based dermal fillers. Comparable as a major HA-consuming aesthetics incumbent and potential commercial partner.
- Sanofi: Diversified global pharma with HA-related consumer health and prescription products. Comparable as a broad incumbent participating in HA end markets and a potential strategic acquirer or licensee.
- LG Chem: Korean chemical and life-sciences company producing HA for cosmetics and biopharma applications. Comparable as a diversified incumbent with fermentation/bioprocess capabilities that competes with Hyalose's recombinant platform.
Direct peers
- Seikagaku Corporation: Japanese specialty pharma focused on HA-based products for joint health, ophthalmology, and wound healing. Comparable to Hyalose in its HA-centered product strategy and its focus on regulated, pharma-grade HA applications.
- Contipro: Czech manufacturer producing HA and other polysaccharides for medical devices, cosmetics, and pharma. Direct peer to Hyalose as a HA ingredient/biopolymer manufacturer serving both cosmetic and medical end markets.
- Kewpie Corporation: Japanese food and health-care company with a meaningful HA production business serving cosmetics and medical customers. Comparable as a HA producer that has scaled production beyond pure pharmaceutical use.
- Anika Therapeutics: US specialty pharma built on HA-based therapies for joint preservation, pain management, and ophthalmology. Direct peer to Hyalose in HA-centered therapeutic and regenerative-medicine markets.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat1 record
Key risks5 records
Key highlights3 records
Customer concentration
Hyalose LLC social profiles
Digital presenceHyalose LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hyalose LLC leadership team
Management profileNumber of profiles
Hyalose LLC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hyalose LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hyalose LLC
What does Hyalose LLC do?
Hyalose LLC is a biotechnology company focused on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HA). The firm leverages proprietary recombinant bioprocesses to manufacture HA as a tangible biopolymer product intended for downstream business customers in pharmaceutical, cosmetic, dermatological, ophthalmic, and medical device applications.
When was Hyalose LLC founded?
Hyalose LLC was founded in -1. It employs 1 to 10 people.
Where is Hyalose LLC based?
Hyalose LLC is headquartered in Salt Lake City, United States, in the North America region.
Who are Hyalose LLC's main competitors?
Broad incumbents on record are Bloomage Biotech, AbbVie (Allergan Aesthetics), Galderma, Merz Aesthetics, Sanofi and LG Chem. Direct peers are Seikagaku Corporation, Contipro, Kewpie Corporation and Anika Therapeutics.
Does Hyalose LLC have an API?
No public API is recorded for Hyalose LLC.